Recent Finacing
Recent Raise
Triplet Therapeutics develops ASO and siRNA therapies that target DNA damage response components, using human genetic insights to prevent repeat expansion disorders such as Huntington’s, myotonic dystrophy, and SCAs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Triplet Therapeutics.
